{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:15:48Z","timestamp":1764242148250,"version":"3.46.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["408778\/2022\u20139, 307946\/2022\u20133 and 444735\/2023-2"],"award-info":[{"award-number":["408778\/2022\u20139, 307946\/2022\u20133 and 444735\/2023-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005672","name":"Funda\u00e7\u00e3o de Apoio ao Desenvolvimento do Ensino, Ci\u00eancia e Tecnologia do Estado de Mato Grosso do Sul","doi-asserted-by":"publisher","award":["76\/2023 and 113\/2023"],"award-info":[{"award-number":["76\/2023 and 113\/2023"]}],"id":[{"id":"10.13039\/501100005672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020983","name":"Universidade Federal da Grande Dourados","doi-asserted-by":"publisher","award":["Universidade Federal da Grande Dourados"],"award-info":[{"award-number":["Universidade Federal da Grande Dourados"]}],"id":[{"id":"10.13039\/100020983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s42770-025-01641-w","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:28:54Z","timestamp":1759912134000},"page":"2601-2617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial potential of compounds from the MMV pandemic response box and COVID box against carbapenem-resistant Acinetobacter baumannii"],"prefix":"10.1007","volume":"56","author":[{"given":"Andressa Leite Ferraz","family":"Melo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"de C\u00e1ssia Cerqueira Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline Andrade","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Carvalho","family":"Sturaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia Pimentel","family":"Arantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Carlos Pael","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Laleu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Besson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gleyce Hellen","family":"de Almeida de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2367-0915","authenticated-orcid":false,"given":"Simone","family":"Simionatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"1641_CR1","doi-asserted-by":"publisher","unstructured":"Gasser M, Cassini A, Wong DLF, Gelormini M, Nahrgang SA, Zingg W et al (2023) Associated deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland, 2010 to 2019. Eurosurveillance 28(20):pii=2200532. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.20.2200532","DOI":"10.2807\/1560-7917.ES.2023.28.20.2200532"},{"key":"1641_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jiph.2023.12.007","volume":"17","author":"N Haddad","year":"2024","unstructured":"Haddad N, Zeenny RM, El Halabi C, Abdallah T, El Helou R, Zahreddine NK et al (2024) The experience of an antimicrobial stewardship program and antibiotic consumption and resistance trends during the COVID-19 pandemic at a tertiary care center in Beirut. J Infect Public Health 17:254\u2013262. https:\/\/doi.org\/10.1016\/j.jiph.2023.12.007","journal-title":"J Infect Public Health"},{"key":"1641_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-023-06873-0","volume":"625","author":"C Zampaloni","year":"2024","unstructured":"Zampaloni C, Mattei P, Bleicher K, Winther L, Th\u00e4te C, Bucher C et al (2024) A novel antibiotic class targeting the lipopolysaccharide transporter. Nature 625:566\u2013571. https:\/\/doi.org\/10.1038\/s41586-023-06873-0","journal-title":"Nature"},{"key":"1641_CR4","unstructured":"WHO, Bacterial Priority Pathogens, List (2024) : bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization. 2024 [cited 29 Jun 2024]. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240093461"},{"key":"1641_CR5","doi-asserted-by":"publisher","unstructured":"Verma N, Sharma T, Bhardwaj A, Vemuluri VR (2024) Comparative genomics and characterization of a multidrug-resistant Acinetobacter baumannii VRL-M19 isolated from a crowded setting in India. Infect Genet Evol 118. https:\/\/doi.org\/10.1016\/j.meegid.2023.105549","DOI":"10.1016\/j.meegid.2023.105549"},{"key":"1641_CR6","doi-asserted-by":"publisher","unstructured":"Chukamnerd A, Saipetch N, Singkhamanan K, Ingviya N, Assanangkornchai N, Surachat K et al (2024) Association of biofilm formation, antimicrobial resistance, clinical characteristics, and clinical outcomes among Acinetobacter baumannii isolates from patients with ventilator-associated pneumonia. Clin Respiratory J 18. https:\/\/doi.org\/10.1111\/crj.13732","DOI":"10.1111\/crj.13732"},{"key":"1641_CR7","doi-asserted-by":"publisher","unstructured":"De Blasiis MR, Sciurti A, Baccolini V, Isonne C, Ceparano M, Iera J et al (2024) Impact of antibiotic exposure on antibiotic-resistant Acinetobacter baumannii isolation in intensive care unit patients: a systematic review and meta-analysis. J Hosp Infect W.B. Saunders 143:123\u2013139. https:\/\/doi.org\/10.1016\/j.jhin.2023.11.002","DOI":"10.1016\/j.jhin.2023.11.002"},{"key":"1641_CR8","doi-asserted-by":"publisher","unstructured":"Sabour S, Bantle K, Bhatnagar A, Huang JY, Biggs A, Bodnar J et al (2024) Descriptive analysis of targeted carbapenemase genes and antibiotic susceptibility profiles among carbapenem-resistant Acinetobacter baumannii tested in the Antimicrobial Resistance Laboratory Network-United States, 2017\u20132020. Microbiol Spectr 12. https:\/\/doi.org\/10.1128\/spectrum.02828-23","DOI":"10.1128\/spectrum.02828-23"},{"key":"1641_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2024.01.018","author":"MH Gharaibeh","year":"2024","unstructured":"Gharaibeh MH, Abandeh YM, Elnasser ZA, Lafi SQ, Obeidat HM, Khanfar MA (2024) Multi-drug resistant Acinetobacter baumannii: phenotypic and genotypic resistance profiles and the Associated Risk factors in Teaching Hospital in Jordan. J Infect Public Health 17:543\u2013550. https:\/\/doi.org\/10.1016\/j.jiph.2024.01.018","journal-title":"J Infect Public Health"},{"key":"1641_CR10","doi-asserted-by":"publisher","unstructured":"da Silva MEP, Gomes MA, da Rodrigues S, Lima RS, Carvalho NC, Taborda AG et al (2023) RLM,. Multidrug-resistant Acinetobacter spp. from hospital intensive care units in Brazilian Amazon. Braz J Infect Dis 27. https:\/\/doi.org\/10.1016\/j.bjid.2023.103687","DOI":"10.1016\/j.bjid.2023.103687"},{"key":"1641_CR11","doi-asserted-by":"publisher","unstructured":"Castillo Bejarano JI, Llaca D\u00edaz J, La E, Cavazos O, S\u00e1nchez Alan\u00eds ME, De Los Santos H, Espinosa-Villase\u00f1or AH et al (2023) F,. Carbapenem-Resistant Acinetobacter baumannii Infection in Children From a Third-Level Hospital in Mexico: Clinical Characteristics and Molecular Epidemiology. J Pediatric Infect Dis Soc 12:431\u2013435. https:\/\/doi.org\/10.1093\/jpids\/piad046","DOI":"10.1093\/jpids\/piad046"},{"key":"1641_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/cid\/ciad556","volume":"78","author":"M Wang","year":"2024","unstructured":"Wang M, Ge L, Chen L, Komarow L, Hanson B, Reyes J et al (2024) Clinical outcomes and bacterial characteristics of Carbapenem-resistant Acinetobacter baumannii among patients from different global regions. Clin Infect Dis 78:248\u2013258. https:\/\/doi.org\/10.1093\/cid\/ciad556","journal-title":"Clin Infect Dis"},{"key":"1641_CR13","doi-asserted-by":"publisher","unstructured":"Beig M, Parvizi E, Navidifar T, Bostanghadiri N, Mofid M, Golab N et al (2024) Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: a comprehensive meta-analysis. PLoS ONE 19. https:\/\/doi.org\/10.1371\/journal.pone.0311124","DOI":"10.1371\/journal.pone.0311124"},{"key":"1641_CR14","doi-asserted-by":"publisher","unstructured":"Soria-Segarra C, Soria-Segarra C, Molina-Matute M, Agreda-Orellana I, N\u00fa\u00f1ez-Quezada T, Cevallos-Apolo K et al (2024) Molecular epidemiology of carbapenem-resistant Gram-negative bacilli in Ecuador. BMC Infect Dis 24. https:\/\/doi.org\/10.1186\/s12879-024-09248-6","DOI":"10.1186\/s12879-024-09248-6"},{"key":"1641_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jgar.2023.06.011","volume":"34","author":"SM Morgado","year":"2023","unstructured":"Morgado SM, Fonseca \u00c9L, Freitas FS, Bighi NS, Oliveira PPC, Monteiro PM et al (2023) Outbreak of high-risk XDR CRAB of international clone 2 (IC2) in Rio Janeiro, Brazil. J Glob Antimicrob Resist 34:91\u201398. https:\/\/doi.org\/10.1016\/j.jgar.2023.06.011","journal-title":"J Glob Antimicrob Resist"},{"key":"1641_CR16","doi-asserted-by":"publisher","unstructured":"Da Silva KE, Maciel WG, Croda J, Cay\u00f4 R, Ramos AC, De Sales RO et al (2018) A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit. PLoS ONE 13. https:\/\/doi.org\/10.1371\/journal.pone.0209367","DOI":"10.1371\/journal.pone.0209367"},{"key":"1641_CR17","doi-asserted-by":"publisher","unstructured":"Du X, Xu X, Yao J, Deng K, Chen S, Shen Z et al (2019) Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis. Am J Infect Control 47:1140\u20131145. https:\/\/doi.org\/10.1016\/j.ajic.2019.03.003","DOI":"10.1016\/j.ajic.2019.03.003"},{"key":"1641_CR18","doi-asserted-by":"publisher","unstructured":"Harris G, KuoLee R, Xu HH, Chen W (2019) Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice. Sci Rep 9. https:\/\/doi.org\/10.1038\/s41598-019-43000-4","DOI":"10.1038\/s41598-019-43000-4"},{"key":"1641_CR19","unstructured":"The Pandemic Response Box (2024). https:\/\/www.mmv.org\/mmv-open\/pandemic-response-box\/about-pandemic-response-box"},{"key":"1641_CR20","doi-asserted-by":"publisher","unstructured":"dos Santos BR, da Silva Bellini Ramos AB, de Menezes RPB, Scotti MT, Colombo FA, Marques MJ et al (2023) Repurposing the Medicines for Malaria Venture\u2019s COVID Box to discover potent inhibitors of Toxoplasma Gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice. PLoS One 18. https:\/\/doi.org\/10.1371\/journal.pone.0288335","DOI":"10.1371\/journal.pone.0288335"},{"key":"1641_CR21","unstructured":"The Covid Box (2024). https:\/\/www.mmv.org\/mmv-open\/archived-projects\/covid-box"},{"key":"1641_CR22","unstructured":"CLSI. Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Standard, Approval CDM-A (2020) M07 Methods for dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically 11"},{"key":"1641_CR23","doi-asserted-by":"publisher","unstructured":"de Oliveira HC, Castelli RF, Reis FCG, Samby K, Nosanchuk JD, Alves LR et al (2022) Screening of the Pandemic Response Box reveals an association between Antifungal effects of MMV1593537 and the cell wall of Cryptococcus neoformans, Cryptococcus deuterogattii, and Candida Auris. Microbiol Spectr 10. https:\/\/doi.org\/10.1128\/spectrum.00601-22","DOI":"10.1128\/spectrum.00601-22"},{"key":"1641_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2217\/fmb-2022-0085","volume":"18","author":"J Eduvirgem","year":"2023","unstructured":"Eduvirgem J, Rossato L, Melo ALF, Valiente ACM, Pla\u00e7a LF, Wender H et al (2023) Antimicrobial and antibiofilm activities of desloratadine against multidrug-resistant. Future Microbiol 18:15\u201325. https:\/\/doi.org\/10.2217\/fmb-2022-0085","journal-title":"Future Microbiol"},{"key":"1641_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0236505","volume":"15","author":"NG Vasconcelos","year":"2020","unstructured":"Vasconcelos NG, De S\u00e1 Queiroz JHF, Da Silva KE, De Paula Vasconcelos PC, Croda J, Simionatto S (2020) Synergistic effects of Cinnamomum cassia L. essential oil in combination with polymyxin B against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens. PLoS ONE 15:1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0236505","journal-title":"PLoS ONE"},{"key":"1641_CR26","doi-asserted-by":"publisher","unstructured":"Moody J, Synergism Testing (2016) Broth Microdilution Checkerboard and Broth Macrodilution Methods. 4th ed. In: Leber AL, editor. Clinical Microbiology Procedures Handbook. 4:5.16.1\u20135.16.23. https:\/\/doi.org\/10.1128\/9781555818814.ch5.16","DOI":"10.1128\/9781555818814.ch5.16"},{"key":"1641_CR27","doi-asserted-by":"publisher","unstructured":"Mahmoud M, Richter P, Lebert M, Burkovski A (2023) Photodynamic activity of Chlorophyllin and Polyethylenimine on Pseudomonas aeruginosa Planktonic, Biofilm and Persister cells. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms241512098","DOI":"10.3390\/ijms241512098"},{"key":"1641_CR28","doi-asserted-by":"publisher","unstructured":"De Melo ALF, Rossato L, Veloso TC, Cardoso CAL, Velasques J, Simionatto S (2023) Synergy between amikacin and protium heptaphyllum essential oil against polymyxin resistance Klebsiella pneumoniae. J Appl Microbiol 134. https:\/\/doi.org\/10.1093\/jambio\/lxad195","DOI":"10.1093\/jambio\/lxad195"},{"key":"1641_CR29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.phymed.2012.08.010","volume":"19","author":"SY Eid","year":"2012","unstructured":"Eid SY, El-Readi MZ, Wink M (2012) Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells. Phytomedicine 19:1288\u20131297. https:\/\/doi.org\/10.1016\/j.phymed.2012.08.010","journal-title":"Phytomedicine"},{"key":"1641_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/vde.12803","volume":"31","author":"WY Chan","year":"2020","unstructured":"Chan WY, Hickey EE, Khazandi M, Page SW, Trott DJ, Hill PB (2020) In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa. Vet Dermatol 31:138\u2013145. https:\/\/doi.org\/10.1111\/vde.12803","journal-title":"Vet Dermatol"},{"key":"1641_CR31","doi-asserted-by":"publisher","DOI":"10.3791\/2437","author":"GA O\u2019Toole","year":"2010","unstructured":"O\u2019Toole GA (2010) Microtiter dish biofilm formation assay. J Visualized Experiments 47. https:\/\/doi.org\/10.3791\/2437","journal-title":"J Visualized Experiments"},{"key":"1641_CR32","doi-asserted-by":"publisher","unstructured":"Gontijo AVL, Pereira SL, de Lacerda Bonfante H (2022) Can Drug Repurposing be effective against Carbapenem-Resistant Acinetobacter baumannii? Current Microbiology. Springer 79. https:\/\/doi.org\/10.1007\/s00284-021-02693-5","DOI":"10.1007\/s00284-021-02693-5"},{"key":"1641_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1099\/jmm.0.000708","volume":"67","author":"K Dafopoulou","year":"2018","unstructured":"Dafopoulou K, Tsakris A, Pournaras S (2018) Changes in antimicrobial resistance of clinical isolates of Acinetobacter baumannii group isolated in Greece, 2010\u20132015. J Med Microbiol 67:496\u2013498. https:\/\/doi.org\/10.1099\/jmm.0.000708","journal-title":"J Med Microbiol"},{"key":"1641_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-023-04732-4","author":"C Le Terrier","year":"2023","unstructured":"Le Terrier C, Freire S, Nordmann P, Poirel L (2023) Multidrug-resistant Gram-negative clinical isolates with reduced susceptibility\/resistance to cefiderocol: which are the best present and future therapeutic alternatives? Eur J Clin Microbiol Infect Dis 43:339\u2013354. https:\/\/doi.org\/10.1007\/s10096-023-04732-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1641_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09899-5","author":"Y Zhan","year":"2024","unstructured":"Zhan Y, Mao W, Zhao C, Lu D, Chen C, Hu W et al (2024) Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis. BMC Infect Dis 24:967. https:\/\/doi.org\/10.1186\/s12879-024-09899-5","journal-title":"BMC Infect Dis BioMed Cent Ltd"},{"key":"1641_CR36","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10096-024-04833-8","volume":"43","author":"A Oliva","year":"2024","unstructured":"Oliva A, Liguori L, Covino S, Petrucci F, Cogliati-Dezza F, Curtolo A et al (2024) Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study. Eur J Clin Microbiol Infect Dis 43:1149\u20131160. https:\/\/doi.org\/10.1007\/s10096-024-04833-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1641_CR37","doi-asserted-by":"publisher","first-page":"102821","DOI":"10.1016\/j.bjid.2023.102821","volume":"27","author":"MM D\u2019Carmo Sodr\u00e9","year":"2023","unstructured":"D\u2019Carmo Sodr\u00e9 MM, Santana NPS, de Almeida ME, Santana S, Concei\u00e7\u00e3o AO, Fontana R et al (2023) Evaluation of the in vitro activity of Cefiderocol, Ceftazidime\/Avibactam and Meropenem\/Vaborbactam against Multidresistant Bacteria Obtained from patients admitted to a Tertiary Hospital in Southern Brazil. Brazilian J Infect Dis 27:102821. https:\/\/doi.org\/10.1016\/j.bjid.2023.102821","journal-title":"Brazilian J Infect Dis"},{"key":"1641_CR38","doi-asserted-by":"publisher","unstructured":"Miller AA, Moussa SH, McLeod SM (2024) Characterization of Acinetobacter baumannii-Calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK). Antimicrob Agents Chemother 68. https:\/\/doi.org\/10.1128\/aac.01698-23","DOI":"10.1128\/aac.01698-23"},{"key":"1641_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02295-23","author":"M Xu","year":"2023","unstructured":"Xu M, Yao Z, Kong J, Tang M, Liu Q, Zhang X et al (2023) Antiparasitic nitazoxanide potentiates colistin against colistin-resistant Acinetobacter baumannii and Escherichia coli in vitro and in vivo. Microbiol Spectr 12. https:\/\/doi.org\/10.1128\/spectrum.02295-23","journal-title":"Microbiol Spectr"},{"key":"1641_CR40","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1021\/acsinfecdis.1c00527","volume":"8","author":"K Samby","year":"2022","unstructured":"Samby K, Besson D, Dutta A, Patra B, Doy A, Glossop P et al (2022) The pandemic response box-accelerating Drug Discovery efforts after Disease outbreaks. ACS Infect Dis 8:713\u2013720. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00527","journal-title":"ACS Infect Dis"},{"key":"1641_CR41","doi-asserted-by":"publisher","unstructured":"Wang Y, Su J, Zhou Z, Yang J, Liu W, Zhang Y et al (2023) Baicalein Resensitizes Multidrug-Resistant Gram-negative pathogens to doxycycline. Microbiol Spectr 11. https:\/\/doi.org\/10.1128\/spectrum.04702-22","DOI":"10.1128\/spectrum.04702-22"},{"key":"1641_CR42","doi-asserted-by":"publisher","unstructured":"Upmanyu K, Haq QMR, Singh R (2023) Antibacterial and Antibiofilm properties of the Alexidine Dihydrochloride (MMV396785) against Acinetobacter baumannii. Antibiotics 12:1155. https:\/\/doi.org\/10.3390\/antibiotics","DOI":"10.3390\/antibiotics"},{"key":"1641_CR43","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2147\/IDR.S396910","volume":"16","author":"X Zou","year":"2023","unstructured":"Zou X, Jin S, Chen L, Li J, Zhang X, Zhou H et al (2023) Antibacterial activity of Eravacycline against Carbapenem-resistant gram-negative isolates in China: an in vitro study. Infect Drug Resist 16:2271\u20132279. https:\/\/doi.org\/10.2147\/IDR.S396910","journal-title":"Infect Drug Resist"},{"key":"1641_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1304198","author":"X Zhong","year":"2023","unstructured":"Zhong X, Deng K, Yang X, Song X, Zou Y, Zhou X et al (2023) Brevicidine acts as an effective sensitizer of outer membrane-impermeable conventional antibiotics for Acinetobacter baumannii treatment. Front Microbiol 16:2271\u20132279. https:\/\/doi.org\/10.3389\/fmicb.2023.1304198","journal-title":"Front Microbiol"},{"key":"1641_CR45","doi-asserted-by":"publisher","unstructured":"Sivasankar S, Premnath MA, Boppe A, Grobusch MP, Jeyaraj S (2023) Screening of MMV pandemic response and pathogen box compounds against pan-drug-resistant Klebsiella pneumoniae to identify potent inhibitory compounds. New Microbes New Infect 55. https:\/\/doi.org\/10.1016\/j.nmni.2023.101193","DOI":"10.1016\/j.nmni.2023.101193"},{"key":"1641_CR46","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1128\/AAC.01248-10","volume":"55","author":"S Escaich","year":"2011","unstructured":"Escaich S, Prouvensier L, Saccomani M, Durant L, Oxoby M, Gerusz V et al (2011) The MUT056399 inhibitor of FabI is a new antistaphylococcal compound. Antimicrob Agents Chemother 55:4692\u20134697. https:\/\/doi.org\/10.1128\/AAC.01248-10","journal-title":"Antimicrob Agents Chemother"},{"key":"1641_CR47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2165\/00003495-199549040-00007","volume":"49","author":"B Fulton","year":"1995","unstructured":"Fulton B, Wagstaff AJ, McTavish D, Trimetrexate (1995) A review of its Pharmacodynamic and Pharmacokinetic properties and therapeutic potential in the treatment of Pneumocystis Carinii Pneumonia. Drugs 49:563\u2013576. https:\/\/doi.org\/10.2165\/00003495-199549040-00007","journal-title":"Drugs"},{"key":"1641_CR48","doi-asserted-by":"publisher","unstructured":"Lim JS, Chai YY, Ser WX, Van Haeren A, Lim YH, Raja T et al (2024) Novel drug candidates against antibiotic-resistant microorganisms: A review. Iranian Journal of Basic Medical Sciences. Mashhad Univ Med Sci 27:134\u2013150. https:\/\/doi.org\/10.22038\/IJBMS.2023.71672.15593","DOI":"10.22038\/IJBMS.2023.71672.15593"},{"key":"1641_CR49","doi-asserted-by":"publisher","unstructured":"Butler MS, Paterson DL (2020) Antibiotics in the clinical pipeline in October 2019. Journal of Antibiotics. Springer Nature 73:329\u2013364. https:\/\/doi.org\/10.1038\/s41429-020-0291-8","DOI":"10.1038\/s41429-020-0291-8"},{"key":"1641_CR50","doi-asserted-by":"publisher","unstructured":"Arends SJR, Butler D, Scangarella-Oman N, Castanheira M, Mendes RE (2023) Antimicrobial activity of Gepotidacin tested against Escherichia coli and Staphylococcus saprophyticus isolates causing urinary tract infections in Medical centers Worldwide (2019 to 2020). Antimicrob Agents Chemother 67. https:\/\/doi.org\/10.1128\/aac.01525-22","DOI":"10.1128\/aac.01525-22"},{"key":"1641_CR51","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1128\/AAC.02955-14","volume":"58","author":"B Mensa","year":"2014","unstructured":"Mensa B, Howell GL, Scott R, DeGrado WF (2014) Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16. Antimicrob Agents Chemother 58:5136\u20135145. https:\/\/doi.org\/10.1128\/AAC.02955-14","journal-title":"Antimicrob Agents Chemother"},{"key":"1641_CR52","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/jmv.27616","volume":"94","author":"Y Hu","year":"2022","unstructured":"Hu Y, Jo H, DeGrado WF, Wang J (2022) Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell. J Med Virol 94:2188\u20132200. https:\/\/doi.org\/10.1002\/jmv.27616","journal-title":"J Med Virol"},{"key":"1641_CR53","doi-asserted-by":"publisher","unstructured":"Mohamed MF, Abdelkhalek A, Seleem MN (2016) Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus. Sci Rep 6. https:\/\/doi.org\/10.1038\/srep29707","DOI":"10.1038\/srep29707"},{"key":"1641_CR54","doi-asserted-by":"crossref","unstructured":"Wang L, Chen Q-W, Qin Y-C, Yi X-L, Zeng H (2024) Analysis of carbapenem-resistant Acinetobacter baumannii carbapenemase gene distribution and biofilm formation. Int J Mol Epidemiol Genet 15(1):1\u201311","DOI":"10.62347\/KBSB9946"},{"key":"1641_CR55","doi-asserted-by":"crossref","unstructured":"Derycke L, P\u00e9rez-Novo C, Van Crombruggen K, Corriveau M-N, Bachert C (2010) Staphylococcus aureus and Chronic Airway Disease. WAO J 3:223\u2013228","DOI":"10.1097\/WOX.0b013e3181ecd8ae"},{"key":"1641_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17144923","volume":"MDPI","author":"V Checchi","year":"2020","unstructured":"Checchi V, Maravic T, Bellini P, Generali L, Consolo U, Breschi L et al (2020) The role of matrix metalloproteinases in periodontal disease. Int J Environ Res Public Health 17:1\u201313. https:\/\/doi.org\/10.3390\/ijerph17144923","journal-title":"Int J Environ Res Public Health"},{"key":"1641_CR57","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s11274-013-1252-1","volume":"29","author":"FM Husain","year":"2013","unstructured":"Husain FM, Ahmad I (2013) Doxycycline interferes with quorum sensing-mediated virulence factors and biofilm formation in Gram-negative bacteria. World J Microbiol Biotechnol 29:949\u2013957. https:\/\/doi.org\/10.1007\/s11274-013-1252-1","journal-title":"World J Microbiol Biotechnol"},{"key":"1641_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31183\/imcp.2024.00091","volume":"7","author":"L Yetendje Chimi","year":"2024","unstructured":"Yetendje Chimi L, Agokeng AJ, Njateng GSS, Dzoyem JP (2024) Effect of combination of doxycycline with natural products against planktonic cells, biofilm, and virulence factor of Pseudomonas aeruginosa. Invest Med Chem Pharmacol 7:1\u20138. https:\/\/doi.org\/10.31183\/imcp.2024.00091","journal-title":"Invest Med Chem Pharmacol"},{"key":"1641_CR59","doi-asserted-by":"publisher","unstructured":"Kim T, Hanh BTB, Heo B, Quang N, Park Y, Shin J et al (2021) A screening of the MMV pandemic response box reveals epetraborole as a new potent inhibitor against Mycobacterium abscessus. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22115936","DOI":"10.3390\/ijms22115936"},{"key":"1641_CR60","doi-asserted-by":"publisher","unstructured":"Bello SO, Yunusa A, Adamu AA, Imam MU, Bello MB, Shuaibu A et al (2023) Innovative, rapid, high-throughput method for drug repurposing in a pandemic\u2014A case study of SARS-CoV-2 and COVID-19. Front Pharmacol 14. https:\/\/doi.org\/10.3389\/fphar.2023.1130828","DOI":"10.3389\/fphar.2023.1130828"},{"key":"1641_CR61","doi-asserted-by":"publisher","unstructured":"Deolankar MS, Carr RA, Fliorent R, Roh S, Fraimow H, Carabetta VJ (2022) Evaluating the efficacy of Eravacycline and Omadacycline against extensively drug-resistant Acinetobacter baumannii Patient isolates. Antibiotics 11. https:\/\/doi.org\/10.3390\/antibiotics11101298","DOI":"10.3390\/antibiotics11101298"},{"key":"1641_CR62","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1016\/j.sjbs.2020.09.025","volume":"27","author":"F Zhang","year":"2020","unstructured":"Zhang F, Ramachandran G, Mothana RA, Noman OM, Alobaid WA, Rajivgandhi G et al (2020) Anti-bacterial activity of chitosan loaded plant essential oil against multi drug resistant K. pneumoniae. Saudi J Biol Sci 27:3449\u20133455. https:\/\/doi.org\/10.1016\/j.sjbs.2020.09.025","journal-title":"Saudi J Biol Sci"},{"key":"1641_CR63","doi-asserted-by":"publisher","unstructured":"Oliveira PR, Carvalho VC, Uip DE, Lima ALLM (2023) Outpatient parenteral antimicrobial therapy in Brazil. Ther Adv Infect Dis 10:1\u20138. https:\/\/doi.org\/10.1177\/20499361231178625","DOI":"10.1177\/20499361231178625"},{"key":"1641_CR64","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2147\/IDR.S172137","volume":"11","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, He X, Li J (2018) Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis. Infect Drug Resist 11:1083\u20131095. https:\/\/doi.org\/10.2147\/IDR.S172137","journal-title":"Infect Drug Resist"},{"key":"1641_CR65","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1128\/AAC.01230-13","volume":"57","author":"O Zusman","year":"2013","unstructured":"Zusman O, Avni T, Leibovici L, Adler A, Friberg L, Stergiopoulou T et al (2013) Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother 57:5104\u20135111. https:\/\/doi.org\/10.1128\/AAC.01230-13","journal-title":"Antimicrob Agents Chemother"},{"key":"1641_CR66","doi-asserted-by":"publisher","unstructured":"Brennan-Krohn T, Kirby JE (2019) When one drug is not enough: Context, Methodology, and future prospects in Antibacterial Synergy Testing. Clinics in Laboratory Medicine. W.B. Saunders, pp 345\u2013358. https:\/\/doi.org\/10.1016\/j.cll.2019.04.002","DOI":"10.1016\/j.cll.2019.04.002"},{"key":"1641_CR67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijmmb.2020.10.018","volume":"39","author":"S Dhandapani","year":"2021","unstructured":"Dhandapani S, Sistla S, Gunalan A, Manoharan M, Sugumar M, Sastry AS (2021) In vitro synergistic activity of colistin and meropenem against clinical isolates of carbapenem resistant Escherichia coli and Klebsiella pneumoniae by checkerboard method. Indian J Med Microbiol 39:6\u201310. https:\/\/doi.org\/10.1016\/j.ijmmb.2020.10.018","journal-title":"Indian J Med Microbiol"},{"key":"1641_CR68","doi-asserted-by":"publisher","unstructured":"Kazemian H, Karami-Zarandi M, Heidari H, Ghanavati R, Khoshnood S (2024) Antimicrobial combination effects against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa strains: a cross-sectional study. Health Sci Rep 7. https:\/\/doi.org\/10.1002\/hsr2.2061","DOI":"10.1002\/hsr2.2061"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-025-01641-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-025-01641-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-025-01641-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:14:21Z","timestamp":1764242061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-025-01641-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1641"],"URL":"https:\/\/doi.org\/10.1007\/s42770-025-01641-w","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"type":"print","value":"1517-8382"},{"type":"electronic","value":"1678-4405"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}